The Novo Nordisk Foundation plans to replace the board with a slate of directors led by the foundation’s chair, Lars Rebien ...

The Ozempic maker’s controlling shareholder intends to replace seven directors, including the Denmark-based company’s ...

The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...

The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...

Novo Nordisk's top investor moved to take control of the drugmaker's board on Tuesday, vowing a sharper focus on the key U.S.

Bagsværd, Denmark, 21 October 2025 - Novo Nordisk today announced that the Board of Directors have decided to convene an ...

The current chairman of the Novo Nordisk Foundation, Lars Rebien Sorensen, who served as the pharma's chief executive from ...

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

Novo Nordisk will hold a meeting to elect new board members following a disagreement between the board and its majority shareholder.

The changing of the guard at Novo Nordisk took another turn this week as the company revealed that seven members of its board ...

Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step ...